- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Aloka's SSD-1700 features digital module
Aloka will introduce SSD-1700, a new color-flow ultrasound scannerwith an option available to support digital management of ultrasoundimages. The new scanner employs a similar imaging architectureto Aloka's existing SSD-2000 scanner, but users can add a
Aloka will introduce SSD-1700, a new color-flow ultrasound scannerwith an option available to support digital management of ultrasoundimages. The new scanner employs a similar imaging architectureto Aloka's existing SSD-2000 scanner, but users can add a datamanagement subsystem (DMS) for functions such as image processingand archiving, according to William Jennings, vice president ofsales and marketing for the Wallingford, CT, company. SSD-1700will be shown as a work-in-progress.
The DMS module is like an onboard workstation that lets sonographersarchive up to 1000 gray-scale ultrasound images or 400 color imageson a single magneto-optical disk. Clinicians can also store cineloop images, conduct online and off-line measurements, and loaddata into a PC, Jennings said. DMS images are digitized from thescanner's scan converter into the DICOM 3.0 format, making iteasier to integrate SSD-1700 with a DICOM network.
Aloka will target a price point for SSD-1700 of under $200,000when FDA clearance is received. The scanner has been shippingto international customers for the past several months.
In addition to SSD-1700, Aloka will display images producedwith a new work-in-progress 3-D technique called Volume Mode.Volume Mode creates 3-D surface renderings without the use ofa separate workstation, and Aloka will emphasize ob/gyn imagesreconstructed with the technology.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
